Firm aims for Strong position in molecular dignsotics marts: Biotheranostics spins out from Biom rieux with $32M funding Jan. 22, 2016 By Omar Ford Staff Writer Biotheranostics (San Diego), a specialist in the molecular diagnostics for cancer market, said it raised $32 million and will be spun out from Biomérieux SA (Marcy-l'Étoile, France). The financing was led by MVM Life Science Partners, with participation of Canepa Advanced Healthcare Fund and Healthquest Capital.Read More
Inside the Beltway: FDA cybersecurity workshop shows many issues unresolved Jan. 22, 2016 By Mark McCarty
No device fails: At Least in one Case: Fourth artificial heart patiient in clinical trial dies; Carmat to begin pivotal trial Jan. 22, 2016 By John Brosky
RSS